Literature DB >> 23265372

Telehealth: a perspective approach for visceral leishmaniasis (kala-azar) control in India.

Gouri Sankar Bhunia1, Shreekant Kesari, Nandini Chatterjee, Vijay Kumar, Pradeep Das.   

Abstract

Visceral leishmaniasis, also known as kala-azar, is a vector borne disease caused by the protozoan parasite, L. donovani. Poor and neglected populations in Indian sub-continent are particularly affected by this disease. Due to the diversity of epidemiological situations, no single diagnosis, treatment, or control will be suitable for all. Control measures through case findings, treatment, and vector control are seldom used, even where they could be useful. Modern tools like telehealth, using space technology, have now come in handy to address issues of disease surveillance, control checking, and evaluation. The present study focuses on telehealth as a current vector control strategy, perspectives on diagnosis, treatment, and control of visceral leishmaniasis as these deserve more attention and research.

Entities:  

Mesh:

Year:  2012        PMID: 23265372      PMCID: PMC4001574          DOI: 10.1179/2047773212Y.0000000014

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  42 in total

1.  Telehealth and outbreak prevention and control: the foundations and advances of the Pacific Public Health Surveillance Network.

Authors:  Y Souarès
Journal:  Pac Health Dialog       Date:  2000-09

2.  Telemedicine: an emerging health care technology.

Authors:  Mary R Myers
Journal:  Health Care Manag (Frederick)       Date:  2003 Jul-Sep

3.  Influence of topography on the endemicity of Kala-azar: a study based on remote sensing and geographical information system.

Authors:  Gouri S Bhunia; Shreekant Kesari; Algarsamy Jeyaram; Vijay Kumar; Pradeep Das
Journal:  Geospat Health       Date:  2010-05       Impact factor: 1.212

4.  Home-based behavioral health intervention: Use of a telehealth model to address poor adherence to type-1 diabetes medical regimens.

Authors:  Jennifer W Adkins; Eric A Storch; Adam B Lewin; Laura Williams; Janet H Silverstein; Toree Malasanos; Gary R Geffken
Journal:  Telemed J E Health       Date:  2006-06       Impact factor: 3.536

5.  Telehealth services to improve nonadherence: A placebo-controlled study.

Authors:  Carol E Smith; Emily R Dauz; Faye Clements; Florence N Puno; David Cook; Gary Doolittle; William Leeds
Journal:  Telemed J E Health       Date:  2006-06       Impact factor: 3.536

Review 6.  What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings.

Authors:  Sanjay Sood; Victor Mbarika; Shakhina Jugoo; Reena Dookhy; Charles R Doarn; Nupur Prakash; Ronald C Merrell
Journal:  Telemed J E Health       Date:  2007-10       Impact factor: 3.536

7.  Resurgence of Phlebotomus argentipes & Ph. papatasi in parts of Bihar (India) after DDT spraying.

Authors:  A K Mukhopadhyay; A K Chakravarty; V R Kureel
Journal:  Indian J Med Res       Date:  1987-02       Impact factor: 2.375

8.  Mapping of risk prone areas of kala-azar (Visceral leishmaniasis) in parts of Bihar State, India: an RS and GIS approach.

Authors:  S Sudhakar; T Srinivas; A Palit; S K Kar; S K Battacharya
Journal:  J Vector Borne Dis       Date:  2006-09       Impact factor: 1.688

9.  Application of mobile-technology for disease and treatment monitoring of malaria in the "Better Border Healthcare Programme".

Authors:  Pongthep Meankaew; Jaranit Kaewkungwal; Amnat Khamsiriwatchara; Podjadeach Khunthong; Pratap Singhasivanon; Wichai Satimai
Journal:  Malar J       Date:  2010-08-19       Impact factor: 2.979

10.  Impact of a preoperative education program via interactive telehealth network for rural patients having total joint replacement.

Authors:  Kathy Thomas; Deborah Burton; Lydia Withrow; Bill Adkisson
Journal:  Orthop Nurs       Date:  2004 Jan-Feb       Impact factor: 0.913

View more
  1 in total

Review 1.  Teleneurology and mobile technologies: the future of neurological care.

Authors:  E Ray Dorsey; Alistair M Glidden; Melissa R Holloway; Gretchen L Birbeck; Lee H Schwamm
Journal:  Nat Rev Neurol       Date:  2018-04-06       Impact factor: 42.937

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.